Integrated Filing — IndAS



General information about company

Scrip Code 534804
NSE Symbol CARERATING
MSEI Symbol NA
ISIN INE752H01013
Name of company CARE RATINGS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 29-10-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 12-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Rating Business & Others
Start date and time of board meeting 29-10-2026   12:00:00
End date and time of board meeting 29-10-2026   18:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 30-01-2025
Indicate Company website link for updated RPT policy of the Company https://www.careratings.com/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 13,420.89 22,236.03
Other income 1,619.94 3,183.36
Total income 15,040.83 25,419.39
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 4,481.36 8,833.22
(e) Finance costs 35.48 72.25
(f) Depreciation, depletion and amortisation expense 232.61 465.42
(f) Other Expenses
1 Other Expenses 1,140.15 2,393.83
Total other expenses 1,140.15 2,393.83
Total expenses 5,889.60 11,764.72
3 Total profit before exceptional items and tax 9,151.23 13,654.67
4 Exceptional items 0.00 0.00
5 Total profit before tax 9,151.23 13,654.67
6 Tax expense
7 Current tax 2,276.01 3,500.94
8 Deferred tax (40.66) (150.51)
9 Total tax expenses 2,235.35 3,350.43
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 6,915.88 10,304.24
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 6,915.88 10,304.24
17 Other comprehensive income net of taxes 27.28 12.87
18 Total Comprehensive Income for the period 6,943.16 10,317.11
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 3,011.84 3,011.84
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 22.98 34.25
Diluted earnings (loss) per share from continuing operations 22.93 34.17
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 22.98 34.25
Diluted earnings (loss) per share from continuing and discontinued operations 22.93 34.17
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on October 29, 2026 and have been subjected to limited review by the statutory auditors of the Company. 2. The Board of Directors of the Company have recommended interim dividend of Rs. 10/- per share. 3. The accompanying financial results have been prepared as per the format prescribed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as modified by Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016. 4. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended from time to time) read with section 133 of the Companies Act, 2013. 5. The Company entered into definitive agreements with State Bank of India and NSE IFSC Limited on 19 October 2026 for the sale of a 9.90% equity stake each in its wholly owned subsidiary, CareEdge Global IFSC Limited (CGIL). Upon completion of the transaction, the Company's shareholding in CGIL will be reduced to 80.20%, and CGIL will cease to be a wholly owned subsidiary upon completion of the closing actions and approval of the share transfer by the Board of CGIL. 6. The Company’s business activity falls within a single primary operating segment viz. ‘Ratings and other related services’. The operating segment has been defined based on regular review by the Company’s Chief Operating Decision Maker to assess the performance of the Company and to make decisions about allocation of resources. 7. The Company has alloted 57,999 equity shares of Rs.10 each pursuant to excercise of employee stock options during Q2 FY 26-27. As per Ind AS 102 - Share Based Payment, total cost of ESOS 2020 is recognised over vesting period. 8. Employee Benefit Expenses in Standalone results includes ESOP charge for Q2FY27 is Rs. 58.83 lakhs and H1FY27 is Rs. 102.68 lakhs.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 7,489.29
Capital work-in-progress 0.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 1,509.00
Intangible assets under development 522.44
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 19,390.58
Trade receivables, non-current 0.00
Loans, non-current 1,559.14
Other non-current financial assets
1 Other financial assets 4,081.04
Total of other non-current financial assets 4,081.04
Total non-current financial assets 25,030.76
Deferred tax assets (net) 0.00
Other non-current assets
1 Other non-current assets 148.18
Total of other non-current assets 148.18
Total non-current assets 34,699.67
2 Current assets
Inventories 0.00
Current financial asset
Current investments 11,326.14
Trade receivables, current 7,062.42
Cash and cash equivalents 7,373.04
Bank balance other than cash and cash equivalents 5,273.99
Loans, current 156.66
Other current financial assets
Total of other current financial assets 52,656.26
Total current financial assets 83,848.51
Current tax assets (net) 308.23
Other current assets
1 Other current assets 871.57
Total of other current assets 871.57
Total current assets 85,028.31
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 1,19,727.98
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 3,011.84
Other equity 1,02,119.10
Total equity attributable to owners of parent 1,05,130.94
Non controlling interest
Total equity 1,05,130.94
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other financial liabilities 1,204.47
Total of other non-current financial liabilities 1,204.47
Total non-current financial liabilities 1,204.47
Provisions, non-current 1,413.75
Deferred tax liabilities (net) 456.45
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 3,074.67
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 12.37
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,251.42
Total Trade payable 1,263.79
Other current financial liabilities
1 Other financial liabilities 2,461.54
Total of other current financial liabilities 2,461.54
Total current financial liabilities 3,725.33
Other current liabilities 6,390.44
1 Other current liabilities 6,390.44
Total of other current liabilities 6,390.44
Provisions, current 353.08
Current tax liabilities (Net) 1,053.52
Deferred government grants, Current 0.00
Total current liabilities 11,522.37
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 14,597.04
Total equity and liabilites 1,19,727.98
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit and loss 36.46 17.20
Total Amount of items that will not be reclassified to profit and loss 36.46 17.20
2 Income tax relating to items that will not be reclassified to profit or loss 9.18 4.33
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 27.28 12.87



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 13,654.67
Adjustments for reconcile profit (loss)
Adjustments for finance costs 72.25
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current 0.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (385.07)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (4,447.56)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 0.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 2,132.45
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 465.42
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (583.49)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 128.72
Adjustments for interest income 2,771.53
Adjustments for share-based payments 102.68
Adjustments for fair value losses (gains) (76.80)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (43.95)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (18.49)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (5,682.81)
Net cash flows from (used in) operations 7,971.86
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,725.04
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 5,246.82
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 5.08
Purchase of property, plant and equipment 380.13
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 2,600.00
Purchase of other long-term assets 12,521.86
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 128.72
Interest received 1,457.22
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 12,957.16
Net cash flows from (used in) investing activities 4,246.19
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 85.64
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 458.01
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 110.38
Dividends paid 4,208.46
Interest paid 72.25
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (3,847.44)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 5,645.57
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 5,645.57
Cash and cash equivalents cash flow statement at beginning of period 1,727.47
Cash and cash equivalents cash flow statement at end of period 7,373.04





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Interest received Approved 63.16 0.00 0.00
2 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Any other transaction Personal Recharge Approved 6.00 0.00 0.00
3 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Any other transaction Reimbursement of Expenses Approved 3.55 0.00 0.00
4 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Any other transaction ESOP Recharge Approved 16.95 (3.22) 9.03
5 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Sale of goods or services Approved 3.50 0.00 0.00
6 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Any other transaction Professional Fees for Advsiory services Approved 29.24 0.00 8.26
7 CARE Ratings Limited CARE ESG Ratings Limited Wholly Owned Subsidiary Any other transaction Rent Income Approved 28.28 0.00 0.00
8 CARE Ratings Limited CARE ESG Ratings Limited Wholly Owned Subsidiary Any other transaction Personal Recharge Approved 6.00 0.00 0.00
9 CARE Ratings Limited CARE ESG Ratings Limited Wholly Owned Subsidiary Any other transaction Business Sourcing fees Approved 8.17 9.53 6.47
10 CARE Ratings Limited CARE Ratings (Africa) Private Limited Subsidiary Any other transaction Royalty Approved 35.89 59.09 35.89
11 CARE Ratings Limited CARE Ratings (Africa) Private Limited Subsidiary Any other transaction IT Recharge Approved 19.56 27.46 19.56
12 CARE Ratings Limited CARE Ratings Nepal Limited Subsidiary Any other transaction IT Recharge Approved 6.34 15.75 8.28
13 CARE Ratings Limited CARE Ratings Nepal Limited Subsidiary Any other transaction Sitting Fees Approved 0.30 0.30 0.09
14 CARE Ratings Limited CARE Ratings Nepal Limited Subsidiary Any other transaction Royalty Approved 19.52 25.10 44.61
15 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction ESOP Recharge Approved 10.89 4.34 5.29
16 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Royalty Approved 46.70 44.93 91.63
17 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Business Sourcing fees Approved 51.97 25.08 35.12
18 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Personal Recharge Approved 6.00 0.00 0.00
19 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Any other transaction Consultancy fees Approved 19.27 0.00 7.98
20 CARE Ratings Limited CARE Ratings (Africa) Private Limited Subsidiary Dividend received Approved 72.00 0.00 0.00
21 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Professional Fees Approved 12.24 0.00 0.00
22 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Salary and related benefit reimbursement Approved 49.94 0.00 0.00
23 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Other reimbursement expenses-receivable Approved 0.91 0.00 0.00
24 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Rent Income Approved 10.23 0.00 0.00
25 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Purchase of fixed assets Approved 60.75 0.00 0.00
26 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Any other transaction AMC related software Approved 0.90 0.00 0.00
27 CARE Ratings Limited CareEdge Global IFSC Limited Wholly Owned Subsidiary Any other transaction Other reimbursement expenses-payable Approved 23.84 0.00 0.00
28 CARE Ratings Limited CARE Ratings South Africa (Pty) Limited Subsidiary Any other transaction Royalty Approved 0.16 0.32 0.49
29 CARE Ratings Limited CARE Ratings South Africa (Pty) Limited Subsidiary Any other transaction IT Recharge Approved 0.00 5.80 5.80
30 CARE Ratings Limited CARE Ratings South Africa (Pty) Limited Subsidiary Any other transaction Professional Fees Approved 0.00 0.75 0.75
31 CARE Ratings Limited CARE Analytics and Advisory Private Limited Wholly Owned Subsidiary Any other transaction Loan given Approved 0.00 1,450.60 1,450.60
Total value of transaction during the reporting period 612.26